Medical Robots and Computer-Assisted Surgery: The Global Market
October 11, 2011
Wellesley, Mass. – In a recent release, MEDICAL ROBOTS AND COMPUTER-ASSISTED SURGERY: THE GLOBAL MARKET (HLC036D) from BCC Research (www.bccresearch.com), the global market for medical robots and computer-assisted surgery (MRCAS) equipment was worth nearly $2 billion in 2010, $2.1 billion in 2011, and is projected to be valued at more than $3.6 billion by 2016, a compound annual growth rate (CAGR) of 11.1% between 2011 and 2016.
The United States accounted for more than two-thirds of the global MRCAS market in 2010, a share that is expected to remain nearly steady through 2016. Europe is the second-largest geographical market for MRCAS with a little less than one-quarter of the market. The Asia-Pacific region is the fastest-growing market, with a 2011-2016 CAGR of almost 17%.
Medical robotics and computer-assisted surgery technologies are devices or systems used under the direct control of the surgeon that leverage computer technology to enable the surgeon to execute surgical procedures more safely and cost-effectively than would otherwise be the case. MRCAS is used in a growing number of operating rooms around the world, largely as a result of the growing popularity of minimally-invasive surgical (MIS) techniques.
The need to perform delicate surgical procedures safely in tight spaces where the surgeon cannot see directly has created a growing market for devices that act as extensions of the surgeon’s eyes and hands – remote imaging, data processing and feedback, and robotics.
The structure of the hospital industry, the main user of MRCAS, is changing. Private and government health insurers around the world are becoming more cost-conscious, strengthening the case for technologies that can reduce the cost of surgical procedures, like MRCAS.
This report has been written for the medical and surgical devices industry, medical research institutions, investors, and the financial and analyst community. Others who will find the report useful include healthcare executives and healthcare marketing managers.
In addition to HLC036D, BCC also has published HLC098A, HLC099A, and HLC100A. These reports cover medical robots and computer-assisted surgery with focuses, respectively, in the Americas, Europe, and the Asia-Pacific region.
Medical Robotics and Computer-Assisted Surgery: The Global Market( HLC036D )
Publish Date: Sep 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand